Dr. Kristine Joyce L. Porto, MD, PhD, FPNA is a board-certified neurologist, clinical neurogeneticist, and physician-scientist. Above any title, she practices as a physician first — committed to thoughtful, compassionate, evidence-based neurological care for every patient who walks through the door.
My Journey
Medicine, for her, began the way it does for most physicians: in the long hours of training, in learning to sit with patients and their families through uncertainty, and in the particular discipline that neurology demands — the need to think carefully before acting, because the nervous system rarely offers easy answers. Residency in neurology, and the responsibility of chief residency that followed, taught her as much about listening as it did about diagnosis.
It was in clinical practice, encountering patients and families with conditions that had no name and no clear path forward, that a question began to take shape: what happens to the patients whose answers lie not in a scan or a lab value, but in their genes — and who has the training, in the Philippines, to look for them there?
That question led her to Japan, and a PhD in Medicine, specializing in Molecular Neuroscience, at the University of Tokyo. The years that followed were formative in ways that went beyond the laboratory — they taught precision, patience, and a particular kind of humility that comes from working alongside scientists and mentors devoted entirely to getting the details right. She carries that formation with her still.
Returning to the Philippines was never a question of if, only when and how. It meant bringing back not just a set of skills, but a responsibility: to begin building, in a resource-limited setting, the kind of neurogenetic care that had, until then, existed mostly elsewhere.
Clinical Philosophy
Every consultation begins the same way: by listening. Careful clinical phenotyping — a detailed history, a thorough examination, genuine attention to the pattern of a patient’s illness — comes before any test is ordered, genetic or otherwise. Technology, including genomic technology, is there to support clinical judgment, never to replace it.
Genetic testing, in this view, is a tool — one among several, chosen deliberately when it is likely to help, and set aside when it is not. It is never the goal of a consultation, only sometimes the means to one. Every patient is approached individually, on the basis of their own history and needs, because no two patients — and no two families — arrive with quite the same story.
Compassion and scientific rigor are not held in tension in this practice. They are expected to coexist, in every visit, without exception.
Research and Precision Medicine
Research is not separate from the clinic — it exists to serve it. Work in neurogenetics and precision medicine, including translational research and the application of long-read sequencing to complex genomic regions, is undertaken with one purpose in mind: to improve how patients are diagnosed, counseled, and cared for. Building local expertise in these methods matters not as an academic exercise, but because Filipino patients deserve genomic medicine informed by research conducted with their own populations in mind, not assumptions borrowed from elsewhere.
Building for the Philippines
Neurogenetics remains a young field in the Philippines, and building it has meant working across several fronts at once: clinical service, research, education, and the quieter, longer work of capacity building. It has meant training future physician-scientists who can carry this work forward, collaborating with laboratories and institutions both locally and abroad, and treating every one of these efforts as part of a single, connected mission rather than separate projects.
None of this is the work of one person, and it was never meant to be. It is, at its core, an effort to build something durable and locally owned — genomic medicine that is, in the fullest sense, by Filipinos, for Filipinos.
Faith and Vocation
For Dr. Porto, medicine and science are not separate from her faith — they are part of the same calling. Building neurogenetics and precision medicine in a resource-limited setting has meant learning to hold ambition and surrender together: striving for excellence not for prestige, but as an act of faithful stewardship, while trusting that a vision this large was never meant to rest on any one person’s shoulders alone. She hopes her work reflects humility, compassion, integrity, and service — and that it contributes, in time, to a future where more Filipino patients and families have access to the benefits of genomic medicine. This conviction is personal, and it is offered here simply as context for what motivates the work — not as an expectation that patients, colleagues, or collaborators share it.
Selected Credentials
- Board-Certified Neurologist, Philippine Neurologic Association
- PhD in Medicine (Molecular Neuroscience), Graduate School of Medicine, The University of Tokyo
- Fellow, Philippine Neurological Association (FPNA)
- Balik Scientist Awardee, DOST–PCHRD
- Academic and research appointments in the Philippines and Japan, spanning clinical neurology, molecular neuroscience research, and medical education
Looking Ahead
The work ahead is the same work as the work behind: making precision neurology and genomic medicine steadily more accessible in the Philippines, through clinical care, research, education, and collaboration with everyone willing to build alongside. Progress here is necessarily incremental, and much of it is still ahead rather than behind. But it is undertaken with hope, with humility about how much remains to be built, and with a clear sense of purpose about why the work matters.